Abstract | AIMS: METHODS AND RESULTS: A wide range of B-cell and T-cell neoplasms were subjected to immunohistochemical staining with antibodies against BSAP/PAX5 and PAX8 (polyclonal, pPAX8; monoclonal, mPAX8). Ten non-neoplastic lymph node specimens were examined with the same panel. All of the tested neoplastic and non-neoplastic B-cells reacted with the BSAP/PAX5 and pPAX8 antibodies, but did not show reactivity with the mPAX8 antibody. All tested T-cell neoplasms were negative using the BSAP/PAX5, pPAX8 and mPAX8 antibodies. CONCLUSIONS: This is the first study to show the absence of reactivity to an mPAX8 antibody in an expanded panel of B-cell lymphomas as well as in a variety of T-cell neoplasms. In contrast to the mPAX8 antibody, the pPAX8 antibody shows nuclear positivity in non-neoplastic B cells and mature B-cell neoplasms; however, this expression is probably a result of cross-reactivity with PAX5. Given that many laboratories use the pPAX8 antibody, a clear understanding of the differential staining patterns is necessary. The differential diagnosis of a B-cell lymphoma should be entertained when a pPAX8-positive, epithelial marker-negative neoplasm of uncertain primary origin is encountered.
|
Authors | Elizabeth A Morgan, Olga Pozdnyakova, Alessandra F Nascimento, Michelle S Hirsch |
Journal | Histopathology
(Histopathology)
Vol. 62
Issue 3
Pg. 406-13
(Feb 2013)
ISSN: 1365-2559 [Electronic] England |
PMID | 23163626
(Publication Type: Journal Article)
|
Copyright | © 2012 Blackwell Publishing Ltd. |
Chemical References |
- Biomarkers, Tumor
- PAX5 Transcription Factor
- PAX5 protein, human
- PAX8 Transcription Factor
- PAX8 protein, human
- Paired Box Transcription Factors
|
Topics |
- Biomarkers, Tumor
(analysis)
- Humans
- Immunohistochemistry
- Lymphoma, B-Cell
(diagnosis, metabolism)
- Lymphoma, T-Cell
(diagnosis, metabolism)
- PAX5 Transcription Factor
(analysis, biosynthesis)
- PAX8 Transcription Factor
- Paired Box Transcription Factors
(analysis, biosynthesis)
|